The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO. The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years.
Request a Sample Copy of the Global Prefilled Syringes Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946
Top Players Identified in the Prefilled Syringe Market Report:
- Gerresheimer AG
- AptarGroup, Inc.
- Helvoet Rubber & Plastic Technologies BV
- West Pharmaceutical Services Inc.
- SCHOTT AG
- Terumo Corporation
- Nipro PharmaPackaging International
- Other Prominent Players
By Closing system
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
- Complete Syringe Set
- Components & Accessories
- Pharmaceutical & Biotechnology Companies
- Contract Research & Manufacturing Organizations
- North America
- Latin America
- Middle East & Africa
More Trending Topics From Fortune Business [email protected]